It's the last day of #ACSFall2023! Come see #Probius and learn more about how #AI is impacting the #Bioanalytical space with #QES, a bench-top solution that's reagent- and sample prep- less to simplify analytical development​. Booth 1558, just outside the Expo Theatre.

Applied machine/deep learning & #lifesciences are coming together to transform how we understand & improve health. We want to partner w/ teams focused on building wet/dry lab platforms & novel datasets to disrupt traditional drug discovery processes. bit.ly/3FTANT5

There’s no doubt AI will not only improve healthcare, but will also cut healthcare costs. @Accenture estimates that AI applications will cut annual US healthcare costs by $150 B by 2026. #Healthcare #AI

Our commercialization will benefit greatly from Janis’ guidance within the biotechnology market and for biochemical applications. John’s insights into the transformational impact that high-fidelity data can have will help fuel the AI revolution from... businesswire.com/news/home/2…

When you’re changing the way #bioanalysis is done through bridging #biology and #ai, you need deep thinkers with deep connections on your BoD. Probius is proud to add John J. MacWilliams (@Livermore_Comp among others) and Janis Naeve, PhD (@CotaCapital and @amgen Ventures).